Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01FF05	TECENTRIQ	BioTech	Atezolizumab - 1200mg	1200mg	Injectable concentrate for solution	375,054,619 L.L
L01FF05	TECENTRIQ	BioTech	Atezolizumab - 1875mg/15ml	1875mg/15ml	Injectable solution	375,054,619 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 10mg	10mg	Capsule	2,981,987 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 18mg	18mg	Capsule	3,744,073 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 25mg	25mg	Capsule	3,703,630 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 25mg	25mg	Capsule	4,121,565 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 40mg	40mg	Capsule	4,114,846 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 40mg	40mg	Capsule	4,706,136 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 60mg	60mg	Capsule	4,731,669 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 60mg	60mg	Capsule	5,228,891 L.L
C10AA05	ATORVAKEY-10	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	362,837 L.L
C10AA05	LIPODAR	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,323,685 L.L
C10AA05	LIPONORM	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	967,567 L.L
C10AA05	LORVAST	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,114,045 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 10mg	10mg	Tablet	966,287 L.L
C10AA05	STORVAS	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	362,837 L.L
C10AA05	TARDEN	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	688,559 L.L
C10AA05	TORVACOL 10	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, coated	1,128,828 L.L
C10AA05	TORVALIP 10	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	767,910 L.L
C10AA05	TOVAST	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,127,484 L.L
C10AA05	TULIP	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	899,031 L.L
C10AA05	APO-ATORVASTATIN	G	Atorvastatin (calcium) - 10mg	10mg	Tablet	889,624 L.L
C10AA05	ASCOVA	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, scored	1,126,268 L.L
C10AA05	ATORLIP 10	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,052,037 L.L
C10AA05	APO-ATORVASTATIN	G	Atorvastatin (calcium) - 20mg	20mg	Tablet	1,088,378 L.L
C10AA05	ASCOVA	G	Atorvastatin (calcium) - 20mg	20mg	Tablet	1,356,641 L.L
C10AA05	ATORLIP 20	G	Atorvastatin (calcium) - 20mg	20mg	Tablet, film coated	1,279,850 L.L
C10AA05	ATORVAKEY-20	G	Atorvastatin (calcium) - 20mg	20mg	Tablet	362,837 L.L
C10AA05	LIPODAR	G	Atorvastatin (calcium) - 20mg	20mg	Tablet, film coated	2,236,154 L.L
C10AA05	LIPONORM	G	Atorvastatin (calcium) - 20mg	20mg	Tablet, film coated	1,249,774 L.L

...

187